Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

MERCK MILLIPORE SEES EU40M NET COST SAVINGS BY 2017 (GERMAN)


(The following press release from Merck KGaA was received by e-mail. It was not confirmed by the sender.)

Pressemitteilung

Ihr Ansprechpartner Dr. Gangolf Schrimpf +49(0)6151 72 9591

Merck Millipore stellt Führungsposition in der Life-Science-Tools-Branche im Rahmen einer Investorenkonferenz vor

• Sparte ist einem der attraktivsten Segmente der Gesundheitsbranche gut positioniert • Starke Markttrends und stetige Innovation als treibende Kräfte für profitables Wachstum • Sparte will ab 2017 Netto-Kosteneinsparungen von 40 Mio € erzielen

Darmstadt / Molsheim, Frankreich, 5. Dezember 2012 – Merck hat heute im Rahmen einer Veranstaltung für Analysten und Investoren im französischen Molsheim detaillierte Informationen zu seiner Life-Science-Sparte Merck Millipore vorgestellt.

Die komplette Pressemitteilung können Sie über folgenden Link herunterladen: http://news.merck.de/N/0/337A947B47B1137DC1257ACB001C6944/$File/MMDay_d.pdf

Merck Pressemitteilungen erreichen Sie unter folgender Adresse: http://www.merck.de/de/presse/presse.html ________________________________________________________________________________ ____________

Merck KGaA External Communications E-mail: Media.Relations@merck.de Hotline: +49 (0) 6151/72-5000

This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith.

Click http://disclaimer.merck.de to access the German, French, Spanish and Portuguese versions of this disclaimer.

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement